169 related articles for article (PubMed ID: 15473894)
1. Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts.
Voulgarelis M; Giannouli S; Ritis K; Tzioufas AG
Eur J Clin Invest; 2004 Oct; 34(10):690-700. PubMed ID: 15473894
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression.
Giannouli S; Tzoanopoulos D; Ritis K; Kartalis G; Moutsopoulos HM; Voulgarelis M
Ann Rheum Dis; 2004 May; 63(5):578-82. PubMed ID: 15082491
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplasia and autoimmunity.
Giannouli S; Kanellopoulou T; Voulgarelis M
Curr Opin Rheumatol; 2012 Jan; 24(1):97-102. PubMed ID: 22157417
[TBL] [Abstract][Full Text] [Related]
4. [Immunosuppressive treatment of the myelodysplastic syndrome].
Larsen MS; Hasselbalch HC
Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
[TBL] [Abstract][Full Text] [Related]
5. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
Wu L; Li X; Chang C; Ying S; He Q; Pu Q
Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
[TBL] [Abstract][Full Text] [Related]
6. [Myelodysplastic syndromes and autoimmunity].
Stalder G; Alberio L; Ribi C
Rev Med Suisse; 2015 Apr; 11(469):820-2, 824-5. PubMed ID: 26040163
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
8. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation.
Harada H; Kondo T; Ogawa S; Tamura T; Kitagawa M; Tanaka N; Lamphier MS; Hirai H; Taniguchi T
Oncogene; 1994 Nov; 9(11):3313-20. PubMed ID: 7936656
[TBL] [Abstract][Full Text] [Related]
9. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).
Kotsianidis I; Bouchliou I; Nakou E; Spanoudakis E; Margaritis D; Christophoridou AV; Anastasiades A; Tsigalou C; Bourikas G; Karadimitris A; Tsatalas C
Leukemia; 2009 Mar; 23(3):510-8. PubMed ID: 19020538
[TBL] [Abstract][Full Text] [Related]
10. Effect of cA2 anti-tumor necrosis factor-alpha antibody therapy on hematopoiesis of patients with myelodysplastic syndromes.
Boula A; Voulgarelis M; Giannouli S; Katrinakis G; Psyllaki M; Pontikoglou C; Markidou F; Eliopoulos GD; Papadaki HA
Clin Cancer Res; 2006 May; 12(10):3099-108. PubMed ID: 16707608
[TBL] [Abstract][Full Text] [Related]
11. The role of the immune system in myelodysplasia: implications for therapy.
Sloand EM; Rezvani K
Semin Hematol; 2008 Jan; 45(1):39-48. PubMed ID: 18179968
[TBL] [Abstract][Full Text] [Related]
12. Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
Cukrová V; Neuwirtová R; Dolezalová L; Belicková M; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
Exp Hematol; 2009 Mar; 37(3):386-94. PubMed ID: 19136196
[TBL] [Abstract][Full Text] [Related]
13. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?
Braun T; Fenaux P
Best Pract Res Clin Haematol; 2013 Dec; 26(4):327-36. PubMed ID: 24507810
[TBL] [Abstract][Full Text] [Related]
15. The 5q- syndrome and autoimmune phenomena: report of three cases.
Pinheiro RF; Silva MR; Chauffaille Mde L
Leuk Res; 2006 Apr; 30(4):507-10. PubMed ID: 16219353
[TBL] [Abstract][Full Text] [Related]
16. Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.
Aggarwal S; van de Loosdrecht AA; Alhan C; Ossenkoppele GJ; Westers TM; Bontkes HJ
Br J Haematol; 2011 Jun; 153(5):568-81. PubMed ID: 21488861
[TBL] [Abstract][Full Text] [Related]
17. The ambiguous role of interferon regulatory factor-1 (IRF-1) immunoexpression in myelodysplastic syndrome.
Pinheiro RF; Metze K; Silva MR; Chauffaille Mde L
Leuk Res; 2009 Oct; 33(10):1308-12. PubMed ID: 19345417
[TBL] [Abstract][Full Text] [Related]
18. [The myelodysplastic syndrome and autoimmunity].
Laursen SB; Nielsen MØ; Hasselbalch HC
Ugeskr Laeger; 2009 Sep; 171(37):2639-42. PubMed ID: 19758507
[TBL] [Abstract][Full Text] [Related]
19. Immune-induced cytopenia: bone marrow failure syndrome.
Kondo Y; Molldrem JJ
Curr Hematol Rep; 2004 May; 3(3):178-83. PubMed ID: 15087065
[TBL] [Abstract][Full Text] [Related]
20. The relationship between myelodysplastic syndromes and autoimmune disorders.
Zhao S; Mao H; Wang H; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):311-3. PubMed ID: 12411063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
